stimulation of glucagon-like peptide 1 receptors (GLP1R). GLP1R expression/protein has been found on phaeochromocytoma cells ( 42 ) and tumours ( 43 ), but whether they function normally or if they are expressed on cells positive for anti-insulin staining is
Search Results
Ivar Følling, Anna B Wennerstrøm, Tor J Eide, and Hilde Loge Nilsen
Caishun Zhang, Junhua Yuan, Qian Lin, Manwen Li, Liuxin Wang, Rui Wang, Xi Chen, Zhengyao Jiang, Kun Zhu, Xiaoli Chang, Bin Wang, and Jing Dong
including PYY ( 17 ), leptin ( 18 ) and glucagon-like peptide-1 (GLP-1) ( 19 ) are involved in the control of food intake in the LPBN. Besides, our recent research showed that administration of anorexia peptide nesfatin-1 in rats’ LPBN could modulate food
Helle Keinicke, Gao Sun, Caroline M Junker Mentzel, Merete Fredholm, Linu Mary John, Birgitte Andersen, Kirsten Raun, and Marina Kjaergaard
recognized as metabolic regulatory molecules. Stimulation of the BA receptor TGR5 increases EE in BAT as well as GLP-1 secretion in the intestinal L-cells ( 53 ). Also, in gastric bypass patients, increased BA has been suggested to contribute to the improved
Adrian F Daly, Liliya Rostomyan, Daniela Betea, Jean-François Bonneville, Chiara Villa, Natalia S Pellegata, Beatrice Waser, Jean-Claude Reubi, Catherine Waeber Stephan, Emanuel Christ, and Albert Beckers
, dipeptiyl peptidase-4 (DPP-4) inhibitors, a sulfonylurea and GLP-1 agonists. HbA1c was eventually brought down to <7% with the addition of insulin glargine. With chronic treatment using pasireotide LAR 40 mg/month, IGF-1 levels continually trended downwards
Pernille H Hellmann, Jonatan I Bagger, Katrine R Carlander, Katrine B Hansen, Julie L Forman, Joachim Størling, Elizaveta Chabanova, Jens Holst, Tina Vilsbøll, and Filip K Knop
and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects . Journal of Clinical Endocrinology and Metabolism 2011 96 447 – 453 . ( https
Hong Wang, Jie Cao, Jian-bin Su, Xue-qin Wang, Dong-mei Zhang, and Xiao-hua Wang
alone, insulin treatments, insulin-secretagogues, pioglitazone, α-glucosidase inhibitors (AGIs), glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dipeptidyl peptidase 4 inhibitors (DPP-4Is). The BMI was calculated as the ratio of the weight (kg
Tsuneo Ogawa and Adolfo J de Bold
ANF and its sensitivity to PTX (46) . An involvement of glucagon-like peptide-1 (GLP1) has recently been implicated in the regulation of ANF secretion from the heart. GLP1 is one of the incretin hormones secreted from endocrine cells located in the
Cecília Cristelo, Alexandra Machado, Bruno Sarmento, and Francisco Miguel Gama
Diabetes Association . Diabetes Care 2015 38 1964 – 1974 . ( https://doi.org/10.2337/dc15-1419 ) 21 Doggrell SA Do glucagon-like peptide-1 receptor (GLP-1R) agonists have potential as adjuncts in the treatment of type 1 diabetes? Expert Opinion
Melinda Kertész, Szilárd Kun, Eszter Sélley, Zsuzsanna Nagy, Tamás Kőszegi, and István Wittmann
decreasing insulin resistance (e.g. sodium-glucose cotransporter-2 inhibitors or GLP-1 receptor agonists) on the T3. There are some other important data related to the T3 level and T3/T4 ratio in obese patients ( 32 ). After 6 months of gastric banding of
Anna C Simcocks, Kayte A Jenkin, Lannie O’Keefe, Chrishan S Samuel, Michael L Mathai, Andrew J McAinch, and Deanne H Hryciw
), adiponectin (AdipoGen, Liestal, Switzerland), glucagon-like peptide 1 (GLP-1), ghrelin, leptin (Bioplex hormone immunoassay; Bio-Rad Laboratories), erythropoietin (EPO), growth regulated α protein/keratinocyte chemoattractant (GROC/KC), interferon gamma (IFN
